David Levison
Infectious Diseases
Pacific Edge
New Zealand
Biography
David Levison has spent 25 years in the health care industry, from pharmaceuticals to services to diagnostics. He has been the CEO and Director of several molecular diagnostic companies and most recently founded and was the CEO of CardioDx, a US molecular diagnostics company. He is currently the Chief Strategic Officer and Director of CardioDx, a successful medical diagnostics company similar in nature to Pacific Edge. Prior to launching CardioDx, David was a Venture Partner at TPG Ventures and was the CEO of XDx. Previously, he was the founder, President and CEO of iScribe (which was sold to AdvancePCS-now Caremark in December, 2001). Prior to iScribe, David was President of Oncology Therapeutics Network (sold to Bristol-Myers Squibb in 1996). David also served as CFO of OTN's parent company, Axion, from 1990 to 1993. Prior to Axion, he was with Cole Gilburne Fund, an early stage, technology focused venture capital firm.
Research Interest
-
